Method of Increasing Luminal Scaffolding for Biliary Strictures

Author(s):  
S. Lowell Kahn

Benign biliary strictures are a common clinical entity encountered by the interventionalist. Balloon dilatation is an acceptable modality of treatment, but restenosis is frequent. The recoil that follows balloon dilatation of recalcitrant benign biliary strictures presents a treatment challenge. This chapter presents a single-access dual-drainage catheter technique that has been employed successfully for more than 6 years. The procedure involves the standard placement of a large drainage catheter (ideally 14 Fr) across the biliary stricture. A second catheter measuring between 5 and 8.5 Fr is advanced through the hub of the 14 Fr drainage catheter and subsequently exits through a proximal hole of the 14 Fr drainage catheter. At the site of the stricture, there is side-by-side placement of the two drainage catheters providing extra scaffolding despite the 14 Fr percutaneous tract.

Radiology ◽  
1984 ◽  
Vol 151 (3) ◽  
pp. 613-616 ◽  
Author(s):  
E Salomonowitz ◽  
W R Castaneda-Zuniga ◽  
G Lund ◽  
A H Cragg ◽  
D W Hunter ◽  
...  

2018 ◽  
Vol 4 (1) ◽  
pp. 60-67
Author(s):  
Bharath Kumar Bhat ◽  
Shailendra Lalwani ◽  
Siddharth Mehrotra ◽  
Vivek Mangla ◽  
Amitabh Yadav ◽  
...  

The most common cause of Benign Biliary Stricture is post cholecystectomy bile duct injury. Following introduction of the laparoscopic cholecystectomy procedure the incidence of bile duct injury and stricture has increased. The studies suggest that the incidence remained stable even after the improved learning curve. The early diagnosis and prompt management is the key in preventing devastating sequelae of this benign condition. The management of post cholecystectomy biliary strictures involves a multidisciplinary approach. Our review aims to describe the present strategy in management of post cholecystectomy biliary strictures.


2009 ◽  
Vol 153 (2) ◽  
pp. 153-156 ◽  
Author(s):  
Rohit Philip Thomas ◽  
Martin Kocher ◽  
Marie Cerna ◽  
Jiri Kozak ◽  
Stanislav Burval ◽  
...  

2014 ◽  
Vol 37 (6) ◽  
pp. 1559-1567 ◽  
Author(s):  
Jan Jaap Janssen ◽  
Otto M. van Delden ◽  
Krijn P. van Lienden ◽  
Erik A. J. Rauws ◽  
Olivier R. C. Busch ◽  
...  

2021 ◽  
pp. 1-10
Author(s):  
Wen-Hao Qin ◽  
Jun-Teng Liu ◽  
Shu-Ping Wang ◽  
Zhi-Shi Yang ◽  
Kun-Ke Wang ◽  
...  

BACKGROUND: Distinguishing between benign and malignant bile duct strictures has long been a diagnostic challenge in clinical practice. OBJECTIVE: This study aimed to discover novel biomarkers in bile to improve the diagnostic accuracy of malignant biliary strictures. METHODS: Bile samples were collected from 6 patients with malignant or benign biliary stricture, respectively. Protein profiles of the bile were analyzed with a semi-quantitative human antibody array of 440 proteins. Then the differential expressed proteins were screened by Venn diagram analysis. Following this, the accuracy of these potential biomarkers for discriminating between malignant and non-malignant biliary strictures was validated in a larger (n= 40) group of patients using lasso analysis. Results: Twenty proteins were found differentially expressed in malignant versus benign biliary strictures, 6 of which were identified by Venn diagram analysis to be up-regulated regardless of the location of biliary strictures. Among the 6 biomarkers, bile lipocalin-2, P-cadherin, and adipsin showed better diagnostic utility than that of bile CA19-9. Lasso analysis identified that lipocalin-2, P-cadherin and CA19-9 as a group of makers best distinguished malignant from benign strictures. CONCLUSIONS: Lipocalin-2 and P-cadherin measurements in bile could be clinically useful for the detection of malignant biliary strictures.


1987 ◽  
Vol 149 (5) ◽  
pp. 945-948 ◽  
Author(s):  
JJ Trambert ◽  
KM Bron ◽  
AB Zajko ◽  
TE Starzl ◽  
S Iwatsuki

Sign in / Sign up

Export Citation Format

Share Document